REFERENSI
HOLZBEIERLEIN, Jeffrey M., et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline: 2024 amendment. The Journal of urology, 2024, 211.4: 533-538.
POWLES, T., et al. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆. Annals of Oncology, 2022, 33.3: 244-258.
WITJES, J. Alfred, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. European urology, 2021, 79.1: 82-104.
FLAIG, Thomas W., et al. NCCN guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network, 2022, 20.8: 866-878.
COMPÉRAT, Eva, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. The Lancet, 2022, 400.10364: 1712-1721.
